Key Insights

Highlights

Treatment Research

6 treatments under study, led by Radiotherapy

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2/3 (1)

Trial Status

Not Yet Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT07398651Not ApplicableNot Yet Recruiting

Apremilast and Adalimumab in Psoriatic Arthritis Patients

NCT05433597Phase 2/3Not Yet Recruiting

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

Showing all 2 trials

Research Network

Common Treatments

  • Radiotherapy1
  • Tnf1
  • Cisplatin1
  • 5fu1
  • Adalimumab1

Active Sponsors

  • Sun Yat-sen University1
  • Shanghai Weike Bioscience Co., Ltd.1
  • Tanta University1

Top Investigators

Related Conditions

  • Nasopharyngeal Carcinoma1
  • Chemoradiotherapy1
  • Psoriatic Arthritis1
  • Ultrasound Assessment1

Activity Timeline